chartexchange

KRRO
Korro Bio, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:57:48 PM EST
12.44USD+1.015%(+0.12)158,100
Pre-marketNov 18, 2026 8:54:30 AM EST
12.31USD-0.081%(-0.01)
After-hoursNov 18, 2026 4:26:30 PM EST
12.44USD-0.040%(-0.00)
Loading…
Loading…
170.20M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$12.32
Beta
1.64
52-Week High
$17.35 2026-11-03
52-Week Low
$5.20 2025-12-02
SMA 50
$11.83
SMA 200
$12.16
Avg. Vol 10D
182,372
Avg. Vol 30D
215,527
Avg. Vol 90D
168,883
Relative Vol
0.73
9.57M
1.7500%
545
KRRO Profile

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.

KRRO Performance
PeriodPriceDateChangeBeta
1W14.312026-11-12-13.35%2.986
1M8.912026-10-19+39.17%1.015
3M13.952026-08-19-11.11%0.584
6M9.152026-05-19+35.52%1.192
1Y6.412025-11-19+93.45%1.641
2Y46.632024-11-19-73.41%—
5Y24.622023-11-07-49.63%1.700
KRRO Stock Summary

Korro Bio, Inc. Common Stock (NASDAQ:KRRO) stock price today is $12.40, and today's volume is 158,100. KRRO is up 0.649% today. The 30 day average volume is 215,527. KRRO market cap is $170.20M with 13.73M shares outstanding.